Cerevel Therapeutics Announces Publication in The Lancet of

Emraclidine is being developed as a potential once-daily treatment for schizophrenia without the need for titration Data show clinically meaningful and...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,New York ,United States ,Berlin ,Germany ,Johnh Krystal ,John Renger ,Anna Robinson ,Raymond Sanchez ,Christoph Correll ,Robertl Mcneil Jr ,Psych Congress ,Schizophrenia International Research Society ,Professor Of Translational Research ,American College Of Neuropsychopharmacology ,Zucker School Of Medicine At Hofstra Northwell ,Neuroscience Education Institute Congress ,University Medicine ,Negative Syndrome Scale ,Translational Research ,Yale Department ,Yale School ,Zucker School ,American College ,Cerevel Therapeutics ,Quarterly Report ,Nasdaq Cere ,